Adiponectin deficiency promotes endometrial carcinoma pathogenesis and development via activation of mitogen‐activated protein kinase
- 24 January 2022
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 257 (2) , 146-157
Abstract
Obesity is one of the major risk factors for cancer. Clinical studies have demonstrated that circulating levels of adiponectin are inversely correlated, not only with the extent of adiposity, but also with the incidence of several types of cancer, particularly endometrial cancer (EC). However, thus far, adiponectin remains a correlative factor, without definitive evidence to show a causal effect in EC and the potential mechanism(s) involved. To address this issue, we introduced an Apn‐null mutation into Pten haploid‐deficient (Pten+/−) mice. The Pten heterozygous mutation alone led to the development of EC in less than 30% of female mice; however, when combined with the Apn‐null mutation, the incidence of endometrial lesions rose to at least two‐thirds. Although Apn deficiency did not further potentiate the Akt activation caused by the Pten mutation, it elevated the phosphorylation of mitogen‐activated protein kinase (MAPK) p42/44, indicating activation of the MAPK signaling pathway. Treatment of Apn−/−;Pten+/− mice with a MEK inhibitor blocked the development of EC. Finally, xenografts of a PTEN‐proficient human EC cell line grew faster in Apn‐deficient mice, whereas an adiponectin receptor agonist reduced xenograft growth of a PTEN‐deficient human EC cell line. Thus, reduction of adiponectin activity promotes EC development, at least in the context of Pten mutation, by activating MAPK. © 2022 The Pathological Society of Great Britain and Ireland.Keywords
Funding Information
- Guangdong Provincial Introduction of Innovative Research and Development Team (2016ZT06Y432)
- National Natural Science Foundation of China (81630021)
This publication has 48 references indexed in Scilit:
- The functions and regulation of the PTEN tumour suppressorNature Reviews Molecular Cell Biology, 2012
- Circulating adiponectin levels and risk of endometrial cancer: the prospective Nurses' Health StudyAmerican Journal of Obstetrics and Gynecology, 2011
- Joint Loss of PAX2 and PTEN Expression in Endometrial Precancers and CancerCancer Research, 2010
- MEK Inhibitor PD0325901 Significantly Reduces the Growth of Papillary Thyroid Carcinoma Cells In vitro and In vivoMolecular Cancer Therapeutics, 2010
- Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivoClinical Cancer Research, 2009
- Mice Lacking Adiponectin Show Decreased Hepatic Insulin Sensitivity and Reduced Responsiveness to Peroxisome Proliferator-activated Receptor γ AgonistsJournal of Biological Chemistry, 2006
- Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systemsProceedings of the National Academy of Sciences, 1999
- High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in miceCurrent Biology, 1998
- Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTENCell, 1998
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997